MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$6,851,095
Net Income
-$3,362,110
Net Profit Margin
-49.07%
EPS
-$0.11
Unit: Dollar
Revenue Breakdown
Health Sciences Revenues
Financial Services Revenues
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-09-30
2024-12-31
2024-09-30
Revenue
6,851,095
7,762,183
5,958,143.5*
4,686,312
Cost of revenues
4,844,102
3,753,561
2,519,406*
1,402,920
Research and development
961,458
676,172
546,000.5*
291,962
Litigation settlements and related expenses
-
0
745,602.5*
-1,394
Sales and marketing
1,482,486
1,461,348
1,372,326*
956,983
General and administrative
2,447,074
2,118,273
3,372,716.25*
2,822,253
Depreciation and amortization
51,884
52,135
41,612*
6,629
Strategic review and transaction related expenses
551,824
170,579
189,185.75*
-
Total costs and expenses
10,338,828
8,232,068
7,295,644*
5,482,141
Operating loss
-3,487,733
-469,885
-1,337,500.5*
-795,829
Loss on sale of investment
-
0
-15,552*
32,082
Change in fair value of warrant liability
-
0
-112*
20
Interest and investment income
155,543
336,002
1,671,318.25*
658,339
Gain on bargain purchase
-
-
301,207.5*
-
Interest expense
0
35,984
125,851.5*
195,415
Gain on debt redemption
-
0
70,764.75*
-
Total other income, net
155,543
300,018
1,901,775*
495,026
Net gain before income taxes
-3,332,190
-169,867
564,274.5*
-300,803
Income tax expense
29,920
-18,647
198,095.5*
-95,896
Net gain
-
-151,220
366,179
-204,907
Net gain
-3,362,110
-
366,179
-204,907
Basic EPS
-0.11
0
0.012
-0.01
Diluted EPS
-0.11
0
0.012
-0.01
Basic Average Shares
31,152,930
31,082,725
31,014,967
31,098,180
Diluted Average Shares
31,152,930
31,082,725
31,014,967
31,098,180
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net gain
-$3,362,110
Interest and investment
income
$155,543
Net gain before
income taxes
-$3,332,190
Income tax expense
$29,920
Total other income,
net
$155,543
Health Sciences
Revenues
$5,118,513
Financial Services
Revenues
$1,732,582
Operating loss
-$3,487,733
Revenue
$6,851,095
Total costs and
expenses
$10,338,828
Cost of revenues
$4,844,102
General and
administrative
$2,447,074
Sales and marketing
$1,482,486
Research and development
$961,458
Strategic review and
transaction related...
$551,824
Depreciation and
amortization
$51,884
Buy us a coffee
Forian Inc. (FORA)
Forian Inc. (FORA)